CR20150360A - Sistema de liberación transdérmica - Google Patents
Sistema de liberación transdérmicaInfo
- Publication number
- CR20150360A CR20150360A CR20150360A CR20150360A CR20150360A CR 20150360 A CR20150360 A CR 20150360A CR 20150360 A CR20150360 A CR 20150360A CR 20150360 A CR20150360 A CR 20150360A CR 20150360 A CR20150360 A CR 20150360A
- Authority
- CR
- Costa Rica
- Prior art keywords
- release system
- transdermal release
- transdermal
- patient
- therapeutic system
- Prior art date
Links
- RMRJXGBAOAMLHD-IHFGGWKQSA-N buprenorphine Chemical compound C([C@]12[C@H]3OC=4C(O)=CC=C(C2=4)C[C@@H]2[C@]11CC[C@]3([C@H](C1)[C@](C)(O)C(C)(C)C)OC)CN2CC1CC1 RMRJXGBAOAMLHD-IHFGGWKQSA-N 0.000 abstract 2
- 229960001736 buprenorphine Drugs 0.000 abstract 2
- 230000001225 therapeutic effect Effects 0.000 abstract 2
- 239000012790 adhesive layer Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7092—Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Neurosurgery (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261736342P | 2012-12-12 | 2012-12-12 | |
| PCT/EP2013/076325 WO2014090921A1 (en) | 2012-12-12 | 2013-12-12 | Transdermal delivery system |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CR20150360A true CR20150360A (es) | 2015-08-21 |
Family
ID=49816915
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CR20150360A CR20150360A (es) | 2012-12-12 | 2015-07-09 | Sistema de liberación transdérmica |
Country Status (26)
| Country | Link |
|---|---|
| US (3) | US20150306093A1 (enExample) |
| EP (1) | EP2931263A1 (enExample) |
| JP (1) | JP2016502989A (enExample) |
| KR (1) | KR20150096460A (enExample) |
| CN (1) | CN105007906A (enExample) |
| AP (1) | AP2015008525A0 (enExample) |
| AR (1) | AR093940A1 (enExample) |
| AU (1) | AU2013205080B2 (enExample) |
| BR (1) | BR112015013660A2 (enExample) |
| CA (1) | CA2894960A1 (enExample) |
| CL (1) | CL2015001577A1 (enExample) |
| CR (1) | CR20150360A (enExample) |
| DE (1) | DE112013005945T5 (enExample) |
| EA (1) | EA201591124A1 (enExample) |
| GB (1) | GB2523715A (enExample) |
| HK (1) | HK1215677A1 (enExample) |
| IL (1) | IL239223A0 (enExample) |
| MX (1) | MX2015007348A (enExample) |
| NZ (1) | NZ628092A (enExample) |
| PE (1) | PE20151147A1 (enExample) |
| PH (1) | PH12015501169A1 (enExample) |
| SG (1) | SG11201504286VA (enExample) |
| TN (1) | TN2015000201A1 (enExample) |
| TW (1) | TW201438765A (enExample) |
| WO (1) | WO2014090921A1 (enExample) |
| ZA (1) | ZA201504964B (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102006054731B4 (de) | 2006-11-21 | 2013-02-28 | Lts Lohmann Therapie-Systeme Ag | Transdermales therapeutisches System zur Verabreichung des Wirkstoffs Buprenorphin und Verwendung desselben in der Schmerztherapie |
| EA201491164A1 (ru) | 2011-12-12 | 2014-10-30 | ЭлТиЭс ЛОМАНН ТЕРАПИ-ЗЮСТЕМ АГ | Трансдермальная система доставки |
| WO2014195352A1 (en) | 2013-06-04 | 2014-12-11 | Lts Lohmann Therapie-Systeme Ag | Transdermal delivery system |
| CN107660207B (zh) | 2015-03-10 | 2020-09-29 | 罗德科技公司 | 丁丙诺啡乙酸盐及用于制备丁丙诺啡的方法 |
| EP3349737A4 (en) * | 2015-09-14 | 2019-05-15 | Amneal Pharmaceuticals LLC | SYSTEM FOR TRANSDERING |
| KR101695603B1 (ko) * | 2016-11-08 | 2017-01-12 | 이창우 | 병목 하단 밀착 구조의 점탄성 연결캡을 포함하는 니들 디스크 롤러 장치 |
| WO2019064026A1 (en) | 2017-09-29 | 2019-04-04 | Orexo Ab | NEW PHARMACEUTICAL COMPOSITIONS |
| CA3092752A1 (en) * | 2018-03-13 | 2019-09-19 | Lts Lohmann Therapie-Systeme Ag | Transdermal therapeutic system comprising a silicone acrylic hybrid polymer |
| BR112020018300A2 (pt) * | 2018-03-13 | 2020-12-22 | Lts Lohmann Therapie-Systeme Ag | Sistema terapêutico transdérmico compreendendo um polímero híbrido de silicone e acrílico |
| WO2019175101A1 (en) * | 2018-03-13 | 2019-09-19 | Lts Lohmann Therapie-Systeme Ag | Transdermal therapeutic system comprising a silicone acrylic hybrid polymer |
| JP2021517569A (ja) * | 2018-03-13 | 2021-07-26 | エルテーエス ローマン テラピー−ジステーメ アーゲー | シリコーンアクリルハイブリッドポリマーを含む、ブプレノルフィンの経皮投与のための経皮治療システム |
| GB201904767D0 (en) | 2019-04-04 | 2019-05-22 | Orexo Ab | New pharmaceutical compositions |
| CN114025748A (zh) * | 2019-07-09 | 2022-02-08 | 罗曼治疗系统股份公司 | 包括包含含硅酮聚合物的含活性剂层和包含硅酮凝胶粘合剂的皮肤接触层的透皮治疗系统 |
| CN113952319A (zh) * | 2021-11-30 | 2022-01-21 | 烟台大学 | 一种含丁丙诺啡的骨架型透皮贴剂及其制备方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5968547A (en) * | 1997-02-24 | 1999-10-19 | Euro-Celtique, S.A. | Method of providing sustained analgesia with buprenorphine |
| US7270830B2 (en) * | 2002-12-13 | 2007-09-18 | Purdue Pharma L.P. | Transdermal buprenorphine dosage regimen for analgesia |
| CN1943576A (zh) * | 2006-10-27 | 2007-04-11 | 哈尔滨健迪医药技术有限公司 | 丁丙诺啡和/或盐酸丁丙诺啡贴剂基质及其贴剂的制备方法 |
| DE102006054731B4 (de) * | 2006-11-21 | 2013-02-28 | Lts Lohmann Therapie-Systeme Ag | Transdermales therapeutisches System zur Verabreichung des Wirkstoffs Buprenorphin und Verwendung desselben in der Schmerztherapie |
| CN101612141B (zh) * | 2009-07-29 | 2012-10-03 | 考司美德制药株式会社 | 丁丙诺啡贴剂 |
-
2013
- 2013-04-13 AU AU2013205080A patent/AU2013205080B2/en not_active Ceased
- 2013-12-12 PE PE2015000906A patent/PE20151147A1/es not_active Application Discontinuation
- 2013-12-12 GB GB1512243.5A patent/GB2523715A/en not_active Withdrawn
- 2013-12-12 JP JP2015547016A patent/JP2016502989A/ja not_active Abandoned
- 2013-12-12 US US14/650,451 patent/US20150306093A1/en not_active Abandoned
- 2013-12-12 AP AP2015008525A patent/AP2015008525A0/xx unknown
- 2013-12-12 HK HK16103661.4A patent/HK1215677A1/zh unknown
- 2013-12-12 DE DE112013005945.2T patent/DE112013005945T5/de not_active Withdrawn
- 2013-12-12 TW TW102145867A patent/TW201438765A/zh unknown
- 2013-12-12 AR ARP130104652A patent/AR093940A1/es unknown
- 2013-12-12 BR BR112015013660A patent/BR112015013660A2/pt active Search and Examination
- 2013-12-12 MX MX2015007348A patent/MX2015007348A/es unknown
- 2013-12-12 SG SG11201504286VA patent/SG11201504286VA/en unknown
- 2013-12-12 WO PCT/EP2013/076325 patent/WO2014090921A1/en not_active Ceased
- 2013-12-12 NZ NZ628092A patent/NZ628092A/en not_active IP Right Cessation
- 2013-12-12 CA CA2894960A patent/CA2894960A1/en not_active Abandoned
- 2013-12-12 KR KR1020157018513A patent/KR20150096460A/ko not_active Withdrawn
- 2013-12-12 EA EA201591124A patent/EA201591124A1/ru unknown
- 2013-12-12 CN CN201380071638.8A patent/CN105007906A/zh active Pending
- 2013-12-12 EP EP13810924.4A patent/EP2931263A1/en not_active Withdrawn
-
2015
- 2015-05-22 TN TNP2015000201A patent/TN2015000201A1/fr unknown
- 2015-05-26 PH PH12015501169A patent/PH12015501169A1/en unknown
- 2015-06-04 IL IL239223A patent/IL239223A0/en unknown
- 2015-06-08 CL CL2015001577A patent/CL2015001577A1/es unknown
- 2015-07-09 CR CR20150360A patent/CR20150360A/es unknown
- 2015-07-10 ZA ZA2015/04964A patent/ZA201504964B/en unknown
-
2018
- 2018-03-08 US US15/915,369 patent/US20180193333A1/en not_active Abandoned
-
2020
- 2020-04-30 US US16/863,584 patent/US20200253957A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| GB201512243D0 (en) | 2015-08-19 |
| AU2013205080B2 (en) | 2016-07-07 |
| GB2523715A (en) | 2015-09-02 |
| AR093940A1 (es) | 2015-07-01 |
| MX2015007348A (es) | 2016-01-20 |
| HK1215677A1 (zh) | 2016-09-09 |
| ZA201504964B (en) | 2017-11-29 |
| US20180193333A1 (en) | 2018-07-12 |
| TN2015000201A1 (en) | 2016-10-03 |
| US20150306093A1 (en) | 2015-10-29 |
| JP2016502989A (ja) | 2016-02-01 |
| CN105007906A (zh) | 2015-10-28 |
| BR112015013660A2 (pt) | 2017-07-11 |
| PH12015501169A1 (en) | 2015-08-10 |
| NZ628092A (en) | 2017-01-27 |
| PE20151147A1 (es) | 2015-08-06 |
| EA201591124A1 (ru) | 2015-11-30 |
| CA2894960A1 (en) | 2014-06-19 |
| DE112013005945T5 (de) | 2015-08-27 |
| AU2013205080A1 (en) | 2014-06-26 |
| EP2931263A1 (en) | 2015-10-21 |
| IL239223A0 (en) | 2015-07-30 |
| WO2014090921A1 (en) | 2014-06-19 |
| KR20150096460A (ko) | 2015-08-24 |
| SG11201504286VA (en) | 2015-06-29 |
| AP2015008525A0 (en) | 2015-06-30 |
| US20200253957A1 (en) | 2020-08-13 |
| CL2015001577A1 (es) | 2015-10-02 |
| TW201438765A (zh) | 2014-10-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CR20150647A (es) | Sistema de liberación transdérmica | |
| CR20140321A (es) | Sistema de administracion transdermica que contiene buprenofina | |
| MX2019007391A (es) | Sistema terapeutico transdermico que contiene asenapina. | |
| MY188139A (en) | Sodium channel modulators for the treatment of pain | |
| ECSP12011834A (es) | Composición farmacéutica, forma de dosificación farmacéutica, procedimiento para su preparación, métodos para su tratamiento y sus usos. | |
| MX2019007389A (es) | Sistema terapeutico transdermico que contiene asenapina y polisiloxano o poliisobutileno. | |
| UY33370A (es) | Composiciones farmacéuticas comprendiendo un fármaco inhibidor de la DPP4 y de la pioglitazona, procedimientos de preparación y utilización | |
| EP3141603A4 (en) | Gpc3-targeted therapeutic agent for administration to patients for whom gpc3-targeted therapeutic agent therapy is effective | |
| BR112016000350A8 (pt) | métodos de tratamento de lesões inflamatórias da rosácea e usos de uma composição farmacêutica | |
| BR112017008993A2 (pt) | métodos e composições especificamente para o tratamento de transtorno de déficit de atenção | |
| BR112012032008A2 (pt) | anticorpos s100a4 e usos terapêuticos do mesmo | |
| CL2016000313A1 (es) | Compuestos de benzoxaborol tricíclicos y usos de los mismos | |
| MX377089B (es) | Uso de una proteína angiopoyetina modificada en la preparación de un medicamento para prevenir o tratar la malaria cerebral. | |
| AR093118A1 (es) | Composiciones y metodos para la administracion transdermica de anfetamina | |
| MX2014011855A (es) | Sistemas y metodos para tratar una respuesta farmacodinamica adversa inducida por opioides. | |
| AR093940A1 (es) | Sistema de liberacion transdermica, metodo de preparacion | |
| EA201400628A1 (ru) | Трансдермальная терапевтическая система для введения фентанила или его аналога | |
| CR20150266A (es) | Formulaciones de liberación modificada para oprozomib | |
| EA201591450A1 (ru) | Фармацевтический состав, содержащий гликозаминогликан | |
| PY1330684A (es) | Tratamiento de la esclerosis múltiple con una combinación de laquinimod y fampridina | |
| MX2014010989A (es) | Un metabolito de iloperidona para uso en el tratamiento de trastornos psiquiatricos. | |
| MX2015010967A (es) | Formulaciones transdermicas de laquinimod. | |
| AR094879A1 (es) | Formulación oral y suspensión de un fármaco oncológico | |
| UA115307C2 (uk) | Застосування лікарського засобу, що містить рекомбінантний лектин омели для лікування раку шкіри | |
| ECSP16069947A (es) | Formulaciones tópicas de heparina |